CEO, Trajan Scientific and Medical
Stories naming Stephen Tomisich. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A roundup of Australian manufacturing news: a summit keynote, a product launch, a CEO appointment, an acquisition, a quantum HQ, training and supply deals, and a refrigeration deployment.
ASX-listed Trajan has announced it will buy US lab consumables maker CRS, funded by a placement, bank debt and cash; the article also recalls its earlier acquisitions.
Trajan Scientific and Medical lists on the ASX, raising $90 million at $1.20 a share, with a stated $220 million market capitalisation.